Market Cap : 731.99 M | Enterprise Value : 672.14 M | PE Ratio : At Loss | PB Ratio : 1.20 |
---|
NAS:SLGC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SLGC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
SomaLogic's average Accounts Payable for the three months ended in Mar. 2022 was $16.62 Mil. SomaLogic's Cost of Goods Sold for the three months ended in Mar. 2022 was $11.65 Mil. Hence, SomaLogic's Days Payable for the three months ended in Mar. 2022 was 130.18.
The historical rank and industry rank for SomaLogic's Days Payable or its related term are showing as below:
During the past 2 years, SomaLogic's highest Days Payable was 175.64. The lowest was 114.02. And the median was 117.42.
SomaLogic's Days Payable increased from Dec. 2020 (62.99) to Mar. 2022 (130.18). It may suggest that SomaLogic delayed paying its suppliers.
The historical data trend for SomaLogic's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, SomaLogic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, SomaLogic's Days Payable distribution charts can be found below:
* The bar in red indicates where SomaLogic's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SomaLogic's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as
Days Payable (A: Dec. 2021 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (A: Dec. 2020 ) | + | Accounts Payable (A: Dec. 2021 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2021 ) | * | Days in Period |
= | ( (7.064 | + | 15.089) | / | 2 ) | / | 33.463 | * | 365 |
= | 11.0765 | / | 33.463 | * | 365 | ||||
= | 120.82 |
SomaLogic's Days Payable for the quarter that ended in Mar. 2022 is calculated as:
Days Payable (Q: Mar. 2022 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (Q: Dec. 2021 ) | + | Accounts Payable (Q: Mar. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2022 ) | * | Days in Period |
= | ( (15.089 | + | 18.158) | / | 2 ) | / | 11.652 | * | 365 / 4 |
= | 16.6235 | / | 11.652 | * | 365 / 4 | ||||
= | 130.18 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of SomaLogic's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Blakeman Shaun M. | officer: Chief Financial Officer | C/O CANTEL MEDICAL CORP. 150 CLOVE ROAD LITTLE FALLS NJ 07424 |
Margulies Anne H. | director | C/O HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747 |
Post Richard A | director | 998 LACOSTA LANE LANE TREE CO 80124 |
Casdin Eli | director | 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019 |
Cox Troy | director | C/O FOUNDATION MEDICINE, INC. C/O FOUNDATION MEDICINE, INC., 150 SECON CAMBRIDGE MA 02141 |
Meisel Ted D | director | |
Barchi Robert | director | |
Quake Stephen | director | C/O FLUIDIGM CORPORATION 7000 SHORELINE COURT, SUITE 100 SOUTH SAN FRANCISCO CA 94080 |
Lillis Charles M. | director | 13 CASTLE PINES DRIVE N CASTLE ROCK CO 80108 |
Harris Melody | officer: President and COO | 4801 WEST BYRON PLACE DENVER CO 80211 |
Gutierrez Ruben | officer: General Counsel | 6435 AVENIDA WILFREDO LA JOLLA CA 92037 |
Graves Amy | officer: Chief Accounting Officer | 926 PENDLETON AVENUE LONGMONT CO 80504 |
Smythe Roy | director, officer: Chief Executive Officer | 935 10TH STREET BOULDER CO 80302 |
M-lsh Ii Llc | 10 percent owner | 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065 |
C-lsh Ii Llc | 10 percent owner | 1350 6TH AVENUE SUITE 2600 NEW YORK NY 10019 |
From GuruFocus
Other Sources
By Seekingalpha 2021-10-14
By Zacks 2022-02-17
By Seekingalpha 2021-11-15
By Seekingalpha 2022-01-11